drugset / Trial / NCT03199807

Phase IB/II Study of NRT Combined With Radiotherapy for Advanced HCC

NCT03199807 ↗

NaSingle-groupOpen-labelTreatment

Summary

The study herein successfully developed a new immunotherapeutic approach combined with radiotherapy, and tried to proved it to be more effective and safe.

Timeline

Start
2017-07-20
Primary completion
2020-07-20
Completion
2021-07-20

Drugs

EvaluationDrugModalityDoseRoute
Subject NRT Cell therapy 5e+09 cells Intravenous
Subject NRT Cell therapy 1e+10 cells Intravenous